FDA NDC Directory · JSON-LD · Markdown

Lisdexamfetamine dimesylate

NDC 70010-217 · HUMAN PRESCRIPTION DRUG · TABLET, CHEWABLE

Labeler / ManufacturerGranules Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA219258
Dosage form / routeTABLET, CHEWABLE · ORAL
Active ingredientsLISDEXAMFETAMINE DIMESYLATE (40 mg/1)
Marketing started20241217
Package count1

External sources

Source: openFDA. Public-domain (CC0).